Lund Vasculitis Epidemiology Research Group
41 – 50 of 54
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)
(
- Contribution to journal › Article
-
Mark
Comment on : Rituximab therapy for takayasu arteritis: A seven patients experience and a review of the literature
(
- Contribution to journal › Letter
-
Mark
Hospitalizations due to systemic connective tissue diseases: : Secular trends and regional disparities in Sweden, 1998-2016
(
- Contribution to journal › Article
-
Mark
Brief Report : Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein)
(
- Contribution to journal › Article
-
Mark
Incidence And Seasonal Variation Of Biopsy-Proven Giant Cell Arteritis – Revisited: A 20-Year Population-Based Study From Sweden
2018) American College of Rheumatology (ACR) Annual Meeting In Arthritis & Rheumatology 70(Suppl 9).(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis : The influence of ANCA subtype
(
- Contribution to journal › Article
- 2016
-
Mark
Comorbidities in patients with antineutrophil cytoplasmic antibody-associated vasculitis versus the general population
(
- Contribution to journal › Article
-
Mark
Visual complications in patients with biopsy-proven giant cell arteritis : A population-based study
(
- Contribution to journal › Article